Home › COVID-19 and Coronavirus Infections › Washington › Seattle
COVID-19 and Coronavirus Infections clinical trials in Seattle, WA
3 studies for COVID-19 and Coronavirus Infections are looking for participants at sites in and around Seattle (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
RecruitingPhase 3
- Seattle Rheumatology Associates, Seattle
- Swedish Ambulatory Infusion Center- First Hill, Seattle
- Swedish Cancer Institute Treatment Center, Seattle
- and 6 more
Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
RecruitingPhase 3
- Swedish Medical Center, Seattle
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
RecruitingPhase 3
- Seattle Children's Hospital, Seattle
- Fred Hutchinson Cancer Center, Seattle
- Fred Hutchinson Cancer Research Center, Seattle
COVID-19 and Coronavirus Infections trials in other cities
- Washington, DC7 studies
- Houston, TX5 studies
- Durham, NC5 studies
- Dallas, TX5 studies
- Boston, MA5 studies
- Atlanta, GA5 studies
- Los Angeles, CA4 studies
- New York City, NY4 studies
- Hialeah, FL4 studies
- San Francisco, CA3 studies
- Cincinnati, OH3 studies
- Pittsburgh, PA3 studies
Other studies in Seattle
- Non-Small Cell Lung Cancer53 studies
- Cancer (all types)49 studies
- Prostate Cancer42 studies
- Acute Myeloid Leukemia41 studies
- Breast Cancer39 studies
- Metastatic Cancer39 studies
- Colorectal Cancer34 studies
- Lung Cancer33 studies
- Ovarian Cancer30 studies
- Multiple Myeloma22 studies
- Bladder Cancer21 studies
- Myelodysplastic Syndromes21 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.